SOMA GOLD SUBSIDIARY ACHIEVES CARBON NEUTRALITY - A FIRST IN COLOMBIAN MINING
VANCOUVER, BC, May 15, 2025 /CNW/ - Soma Gold Corp. (TSXV: SOMA) (WKN: A2P4DU) (OTC: SMAGF) (the " Company" or " Soma") is pleased to announce that its Colombian subsidiary, Operadora Minera SAS ("Operadora"), has achieved carbon neutrality for the 2023 reporting period. This milestone makes Operadora the first mining company in Colombia to be certified carbon neutral for Scope 1, 2, and 4 emissions under the internationally recognized PAS 2060:2014 standard. For clarity, Scope 1 refers to direct emissions from owned or controlled sources (such as fuel combustion), Scope 2 covers indirect emissions from the generation of purchased electricity, and Scope 4 includes avoided emissions resulting from the use of a product or service that displaces emissions elsewhere, such as improving energy efficiency through more sustainable practices.
The carbon neutrality certification, issued by Bureau Veritas – BVQI Colombia Ltd., is the result of a multi-year effort focused on measuring, reducing, and offsetting greenhouse gas (GHG) emissions. Operadora's sustainability strategy includes a transition to 100% renewable hydroelectric power, major operational efficiencies, and verified offsets through REDD+ projects in the Amazon rainforest.
Héctor Meléndez, Soma's Colombia Country Manager, states, "We are proud to be the first mining company in Colombia to achieve carbon neutrality. This achievement proves that mining can be part of the solution to the global climate challenge and reinforces our commitment to environmental leadership."
Highlights of the Carbon Neutrality Milestone:
66% reduction in GHG emissions since 2021, equal to 2,812 tons of CO₂e.
Remaining emissions – totaling 1,345 t CO ₂ e in 2023 – fully offset using externally verified first-class carbon credits.
The entire process was independently verified and certified by Bureau Veritas.
A Voluntary Alliance for Regeneration
In addition to achieving carbon neutrality, Operadora Minera has signed a voluntary agreement with CORANTIOQUIA, alongside three formalized small-scale miners, to promote environmental regeneration in areas affected by illegal mining. This agreement aims to restore ecosystems, rehabilitate water sources, reforest degraded land, and promote biodiversity through sustainable practices and education programs.
"This agreement reflects our life-centric values and our commitment to leaving a lasting legacy of environmental stewardship," said Héctor Meléndez. "We are proud to partner with local communities and environmental authorities to create a healthier future."
These achievements underscore Soma's long-term commitment to responsible mining, aligning with its strategy to reduce environmental impact, support biodiversity, and deliver long-term value to local communities.
Héctor Meléndez, Soma's Colombia Country Manager, states: "This milestone reflects the dedication and integrity of our entire team in Colombia. Achieving carbon neutrality across multiple emission scopes is no small feat. It's the result of years of hard work, innovation, and a shared vision for sustainable mining. I'm incredibly proud of what we've accomplished together."
ABOUT SOMA GOLD
Soma Gold Corp. (TSXV: SOMA) is a mining company focused on gold production and exploration. The Company owns two adjacent mining properties in Antioquia, Colombia, with a combined milling capacity of 675 tpd. (Permitted for 1,400 tpd). The El Bagre Mill is currently operating and producing. Internally generated funds are being used to finance a regional exploration program.
With a solid commitment to sustainability and community engagement, Soma Gold Corp. is dedicated to achieving excellence in all aspects of its operations.
The Company also owns an exploration property near Tucuma, Para State, Brazil that is currently under option to Ero Copper Corp.
On behalf of the Board of Directors
"Geoff Hampson"
Chief Executive Officer and President
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
All statements, analysis and other information contained in this press release about anticipated future events or results constitute forward-looking statements. Forward-looking statements are often, but not always, identified by the use of words such as "seek", "anticipate", "believe", "plan", "estimate", "expect" and "intend" and statements that an event or result "may", "will", "should", "could" or "might" occur or be achieved and other similar expressions. Forward-looking statements are subject to business and economic risks and uncertainties and other factors that could cause actual results of operations to differ materially from those contained in the forward-looking statements. Forward-looking statements are based on estimates and opinions of management at the date the statements are made. The Company does not undertake any obligation to update forward-looking statements even if circumstances or management's estimates or opinions should change except as required by applicable laws. Investors should not place undue reliance on forward-looking statements.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Cision Canada
2 hours ago
- Cision Canada
Perimeter Announces Closing of Prospectus Offering
TORONTO and DALLAS, June 3, 2025 /CNW/ - Perimeter Medical Imaging AI, Inc. (TSXV: PINK) (OTCQX: PYNKF) (" Perimeter" or the " Company"), a commercial-stage medical technology company, is pleased to announce that it has completed its previously announced prospectus offering (the " Offering") of units of the Company (the " Units") and pre-funded units of the Company. The Offering was completed on a reasonable "best efforts" agency basis pursuant to an agency agreement (the " Agency Agreement") dated May 29, 2025 between the Company and A.G.P. Canada Investments ULC (the " Agent"). Pursuant to the Offering, the Company has issued an aggregate of 10,432,801 Units at a price of $0.30 per Unit (the " Offering Price") for aggregate gross proceeds of $3,129,840. Each Unit is comprised of one common share in the capital of the Company (each a " Common Share") and one Common Share purchase warrant (each a " Warrant"). Each Warrant entitles the holder to acquire an additional Common Share for a period of 60 months, at an exercise price of $0.35. Pursuant to the terms of the Agency Agreement, the Agent was entitled to receive a cash fee equal to 7.0% of the gross proceeds raised under the Offering, and compensation options equal to 5.0% of the aggregate number of Units issued under the Offering (the " Compensation Options"), with a reduced cash commission of 3.5% and Compensation Options equal to 2.5% payable in respect of Units sold to certain purchasers on a president's list. In addition, the Agent will receive no cash commission or Compensation Options with respect to sales to certain insiders of the Company. Each Compensation Option entitles the Agent to buy one Common Share at the same price as the price per Unit under the Offering. The Compensation Options are exercisable until that date which is 36 months following the closing date. The Company intends to use the net proceeds from the Offering to continue the commercialization of its technology, establish clinical evidence and continue product development. The Company also intends to use the net proceeds for working capital and other general corporate purposes. The Company may close additional tranches of the Offering for total gross proceeds of up to $15,000,000 (inclusive of the initial closing). The Offering was completed by way of a short form prospectus dated May 29, 2025 (the " Prospectus"). The Prospectus and the Agency Agreement are available on SEDAR+ at and contain important detailed information about the Offering. This press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of the securities in any jurisdiction in which such offer, solicitation or sale would be unlawful. The securities being offered have not been, nor will they be, registered under the United States Securities Act of 1933, as amended (the " 1933 Act") and may not be offered or sold in the United States or to, or for the account or benefit of, U.S. persons absent registration or an applicable exemption from the registration requirements of the 1933 Act, and applicable state securities laws. Social Capital, a control person of the Company purchased a total of 115,217 Units under the Offering. The placement to such person constituted a "related party transaction" within the meaning of TSX Venture Exchange Policy 5.9 and Multilateral Instrument 61-101 - Protection of Minority Security Holders in Special Transactions (" MI 61-101"). The Company has relied on exemptions from the formal valuation and minority shareholder approval requirements of MI 61- 101 contained in sections 5.5(a) and 5.7(1)(a) of MI 61-101 in respect of related party participation in the placement as neither the fair market value (as determined under MI 61-101) of the subject matter of, nor the fair market value of the consideration for, the transaction, insofar as it involved the related parties, exceeded 25% of the Company's market capitalization (as determined under MI 61-101). The Company has not filed a material change report more than 21 days before the expected closing of the Offering as the details of the Offering and the participants thereof were only finalized shortly before the closing of the Offering. About Perimeter Medical Imaging AI, Inc. Based in Toronto, Canada and Dallas, Texas, Perimeter Medical Imaging AI (TSX-V: PINK) (OTCQX: PYNKF) is a medical technology company driven to transform cancer surgery with ultra-high-resolution, real-time, advanced imaging tools to address areas of high unmet medical need. Available across the U.S., our FDA-cleared Perimeter S-Series OCT system provides real-time, cross-sectional visualization of excised tissues at the cellular level. The breakthrough-device-designated investigational Perimeter B-Series OCT with ImgAssist AI represents our next-generation artificial intelligence technology that is currently being evaluated in a pivotal clinical trial, with support from a grant of up to US$7.4 million awarded by the Cancer Prevention and Research Institute of Texas. The Company's ticker symbol "PINK" is a reference to the pink ribbons used during Breast Cancer Awareness Month. Perimeter B-Series OCT is limited by U.S. law to investigational use and not available for sale in the United States. Perimeter S-Series OCT has 510(k) clearance under a general indication and has not been evaluated by the U.S. FDA specifically for use in breast tissue, breast cancer, other types of cancer, margin evaluation, and reducing re-excision rates. The safety and effectiveness of these uses has not been established. For more information, please visit Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. Forward-Looking Statements This news release contains statements that constitute "forward-looking information" within the meaning of applicable Canadian securities legislation. In this news release, words such as "may," "would," "could," "will," "likely," "believe," "expect," "anticipate," "intend," "plan," "estimate," and similar words and the negative form thereof are used to identify forward-looking statements. Forward-looking information may relate to management's future outlook and anticipated events or results and may include statements or information regarding the future financial position, business strategy and strategic goals, competitive conditions, research and development activities, projected costs and capital expenditures, research and clinical testing outcomes, taxes and plans and objectives of, or involving, Perimeter. Without limitation, statements regarding the use of proceeds from the Offering and the closing of additional tranches, are forward-looking information. Forward-looking statements should not be read as guarantees of future performance or results, and will not necessarily be accurate indications of whether, or the times at or by which, any particular result will be achieved. No assurance can be given that any events anticipated by the forward-looking information will transpire or occur. Forward-looking information is based on information available at the time and/or management's good-faith belief with respect to future events and are subject to known or unknown risks, uncertainties, assumptions, and other unpredictable factors, many of which are beyond Perimeter's control. Such forward-looking statements reflect Perimeter's current view with respect to future events, but are inherently subject to significant medical, scientific, business, economic, competitive, political, and social uncertainties and contingencies. In making forward-looking statements, Perimeter may make various material assumptions, including but not limited to (i) the accuracy of Perimeter's financial projections; (ii) obtaining positive results from trials; (iii) obtaining necessary regulatory approvals; and (iv) general business, market, and economic conditions. Further risks, uncertainties and assumptions include, but are not limited to, those applicable to Perimeter and described in Perimeter's Annual Information Form for the year ended December 31, 2024, which is available on Perimeter's SEDAR+ profile at and could cause actual events or results to differ materially from those projected in any forward-looking statements. Perimeter does not intend, nor does Perimeter undertake any obligation, to update or revise any forward-looking information contained in this news release to reflect subsequent information, events, or circumstances or otherwise, except if required by applicable laws. Contacts Stephen Kilmer Investor Relations Direct: 647-872-4849 Email: [email protected] Adrian Mendes Chief Executive Officer Toll-free: 888-988-7465 (PINK) Email: [email protected]
Cision Canada
5 hours ago
- Cision Canada
BQE Water 2025 Annual General and Special Meeting
VANCOUVER, BC, June 3, 2025 /CNW/ - BQE Water Inc. (TSXV: BQE), a leader in the treatment and management of mine impacted waters, will host its Annual General and Special Meeting for shareholders as noted below. The Management Information Circular outlining the meeting resolutions and Director Nominees will be mailed to all shareholders of record as of May 20, 2025. WHAT 2025 Annual General and Special Meeting WHEN June 26, 2025 at 9:00 am Pacific Time WHERE BQE Water Inc. Suite 200 - 30 East 6th Avenue Vancouver, BC Canada V5T 1J4 About BQE Water BQE Water is a service provider specializing in water treatment and management for metals mining, smelting and refining. We are helping to transform the way the industry thinks about water in the context of natural resource projects by offering services and expertise which enables more sustainable water management practices and improved overall project performance at reduced risks. BQE Water invests in innovation and has developed unique intellectual property through the commercialization of several new technologies at mine sites around the world for organizations including Glencore, Jiangxi Copper, Freeport-McMoRan and the US EPA. BQE Water is headquartered in Vancouver, Canada and trades on the TSX Venture Exchange under the symbol BQE. Visit for more information. Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING INFORMATION Certain information contained herein may not be based on historical fact and therefore constitutes "forward-looking information" under applicable Canadian securities legislation. This includes without limitation statements containing the words "plan", "expect", "project", "estimate", "intend", "believe", "anticipate", "may", "will" and other similar words or expressions. Forward-looking statements are based on the opinions and estimates of management at the date the statements are made, and are subject to a variety of risks, uncertainties and other factors that may cause actual events or results to differ materially from those expressed or implied by such forward-looking statements. Factors that could cause or contribute to such differences include, but are not limited to, the Company's dependence on key personnel and contracts, uncertainty with respect to the profitability of the Company's technologies, competition, technology risk, the Company's ability to protect its intellectual property and proprietary information, fluctuations in commodity prices, currency risk, environmental regulation and the Company's ability to manage growth and other factors described in the Company's filings with the Canadian securities regulators at (including without limitation the factors described in the section entitled "Risks and Uncertainties" in the Company's MD&A for the year ended December 31, 2024). Given these risks and uncertainties, the reader is cautioned not to place undue reliance on forward-looking statements. All forward-looking information contained herein is based on management's current expectations and the Company undertakes no obligation to revise or update such forward-looking information to reflect subsequent events or circumstances, except as required by law. SOURCE BQE Water Inc.
The Market Online
8 hours ago
- The Market Online
Market Open: Pre-market sets pessimistic tone
TSX futures gave up ground on Tuesday, tracking U.S. markets amid growing pessimism about the lasting effects of President Trump's global tariffs. Market Numbers (Futures) TSX: Down (0.5%), 26,248.10. TSXV: Up (1.87%), 707.41. DOW: Down (0.22%), 42,286. NASDAQ: Down (0.10%), 21,533.75. FTSE: Down (0.10%), 8,784.91. In the Headlines: Prime Minister Mark Carney's first meeting with his ministers on June 2nd in Saskatoon was followed by the release of the federal government's framework for fast-tracking strategic infrastructure projects. The government intends to offer two-year approvals for projects ranging from critical minerals to ports, pipelines and nuclear energy. As countries around the world continue to shift from globalization to protectionism driven by Trump tariffs, the Organisation for Economic Co-operation and Development lowered its growth outlook for the global economy to 2.9 per cent in 2025 and 2026, down from March estimates of 3.1 and 3 per cent, respectively. Currency Update (Futures) The Canadian dollar fell to US$0.7277, down from US$0.7280 on Monday, while it gained on the Euro, rising from C$0.6373 to C$0.6393. At the time of writing, Bitcoin has given back 0.33% to C$144,719.38. Commodities (Futures) Natural Gas: Down (1.44%), US$3.31. WTI: Up (1.35%), US$63.30. Gold: Down (0.65%), US$3,375.20. Copper: Down (1.39%), US$4.76. To stay up-to-date on all of your market news head to Join the discussion: Find out what everybody's saying about the global market open on Stockhouse's stock forums and message boards. The material provided in this article is for information only and should not be treated as investment advice. For full disclaimer information, please click here.
